Delivery Order SPE2DB22D3016-SPE2DB24FAQG5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, a delivery order valued at $2,727.68, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The award has a firm fixed price pricing structure and an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for ABRAXANE 100 MG VIALS, with a ceiling value of $3,374.68 and a firm fixed price pricing type. The contract has a period of performance through May 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY7ZM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ABRAXANE 100 MG VIALS. The contract has a ceiling value of $9,439.35 and is a firm fixed-price Delivery Order with an ultimate completion date of June 6, 2024. AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,140.40, is for the delivery of ABRAXANE 100 MG VIALS. This is a Firm Fixed Price Delivery Order contract, with a performance period running through April 10, 2024. The contract did not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCVUA, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of 4,567,874,660 units of the pharmaceutical product ABRAXANE 100 MG VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,382.51 and a period of performance ending on April 11, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,375.16 contract is for the delivery of ABRAXANE 100 MG VIALS and has an ultimate completion date of March 5, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,535.30 firm-fixed-price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, with ID SPE2DB22D3016|SPE2DB24FBBU2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The award has a ceiling value of $7,283.84 and an ultimate completion date of July 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the provision of ABRAXANE 100 MG VIALS. The contract has a potential value of $8,837.51 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAQG5Delivery Order
This federal contract award (SPE2DB22D3016|SPE2DB24FAQG5) was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4564002820 ABRAXANE 100 MG VIALS. The contract is a firm fixed price delivery order with a ceiling value of $2,246.82 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has also received a separate indefinite delivery contract (IDC) from DLA with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 3/18/24 |